LSSUF provides financial support to help small-to-medium sized enterprises based in Ontario to scale up the life sciences sector. As part of the agreement, Conavi is eligible to receive up to $2.5 million CAD over the course of the project to cover up to one-third of eligible project costs related to the commercial launch of the next-generation Novasight Hybrid™ system, subject to certain requirements. Additional details regarding LSSUF can be found at https://www.ontario.ca/page/life-sciences-scale-fund.
"We are incredibly grateful to the Province of Ontario, the Ministry of Economic Development, Job Creation, and Trade, and Minister Victor Fedeli for the ongoing support of Conavi and our vision," said Tom Looby, Chief Executive Officer of Conavi Medical. "Heart disease remains a leading cause of death in Canada and globally, and intravascular imaging has been shown to significantly improve outcomes for patients undergoing coronary procedures. We believe the next-generation Novasight Hybrid™ system is well positioned to become a category leader and help propel the Ontario ecosystem."
"Ontario's Life Sciences Scale-Up Fund is accelerating the development of next-generation health technologies and reinforcing our province's position as a global leader in life science innovation," said Vic Fedeli, Minister of Economic Development, Job Creation and Trade. "Through this partnership, Conavi Medical will advance the design and manufacturing of their cardiovascular imaging technology, ensuring ...
